menu search

XRTX / Why Is Xortx Therapeutics (XRTX) Stock Up 30% Today?

Why Is Xortx Therapeutics (XRTX) Stock Up 30% Today?
There's great news circulating about Xortx Therapeutics (NASDAQ: XRTX ) today. In a clinical study, XORLO, Xortx's orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. Read More
Posted: Jan 19 2023, 11:37
Author Name: InvestorPlace
Views: 110981

XRTX News  

Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?

By InvestorPlace
October 23, 2023

Why Is Xortx Therapeutics (XRTX) Stock Down 27% Today?

Xortx Therapeutics (NASDAQ: XRTX ) stock is sliding lower on Monday as the pharmaceutical company's shares come off of a recent rally. Shares of XRTX more_horizontal

Why Is Xortx Therapeutics (XRTX) Stock Up 110% Today?

By InvestorPlace
October 20, 2023

Why Is Xortx Therapeutics (XRTX) Stock Up 110% Today?

Xortx Therapeutics (NASDAQ: XRTX ) stock is climbing higher on Friday despite a lack of news from the pharmaceutical company. There are no new press more_horizontal

Why Is Xortx Therapeutics (XRTX) Stock Up 30% Today?

By InvestorPlace
January 19, 2023

Why Is Xortx Therapeutics (XRTX) Stock Up 30% Today?

There's great news circulating about Xortx Therapeutics (NASDAQ: XRTX ) today. In a clinical study, XORLO, Xortx's orally administered brand of oxypur more_horizontal

XORTX Therapeutics (XRTX) Stock: Why It Skyrocketed Over 90% Today

By Pulse2
July 13, 2022

XORTX Therapeutics (XRTX) Stock: Why It Skyrocketed Over 90% Today

The stock price of XORTX Therapeutics Inc (NASDAQ: XRTX) skyrocketed by over 90% pre-market today. This is why. more_horizontal

Here's Why XORTX Therapeutics Shares Are Rising

By Benzinga
March 23, 2022

Here's Why XORTX Therapeutics Shares Are Rising

XORTX Therapeutics (NASDAQ: XRTX) shares are trading higher by 54.6% at $1.87 after the company announced the submission of a Patent Cooperation Trea more_horizontal


Search within

Pages Search Results: